Cleerly Patents – Insights & Stats (Updated 2023)

Cleerly has a total of 64 patents globally, out of which 35 have been granted. Of these 64 patents, more than 95% patents are active. United States of America is where Cleerly has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cleerly.

Cleerly was founded in the year 2017. The Company is a digital healthcare company that offers heart disease diagnosis solutions.

Do read about some of the most popular patents of Cleerly which have been covered by us in this article and also you can find Cleerly patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cleerly patent portfolio.

How many patents does the founder and the CEO of Cleerly have?

The founder and CEO James K. Min has 75 patents.

How many patents does Cleerly have?

Cleerly has a total of 64 patents globally. These patents belong to 3 unique patent families. Out of 64 patents, 61 patents are active.

How Many Patents did Cleerly File Every Year?

Cleerly Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCleerly Applications FiledCleerly Patents Granted
2023214
20222415
2021335
202051

How many Cleerly patents are Alive/Dead?

Cleerly Patent Portfolio

 How Many Patents did Cleerly File in Different Countries?

Cleerly Worldwide Patent Filing

Countries in which Cleerly Filed Patents

CountryPatents
United States Of America49
Japan3
Europe3
Canada2
Australia2

Where are Research Centres of Cleerly Patents Located?

The Research Centre for all the Cleerly patents is the United States of America.

10 Best Cleerly Patents

US10813612B2 is the most popular patent in the Cleerly portfolio. It has received 38 citations so far from companies like Elucid Bioimaging, Hangzhou Yitu Medical Technology and Ontact Health.

Below is the list of 10 most cited patents of Cleerly:

Publication NumberCitation Count
US10813612B238
US20210319558A137
US11120549B230
US11120550B230
US11113811B230
US11244451B119
US11238587B218
US11210786B218
US11232564B217
WO2021141921A117

What Percentage of Cleerly US Patent Applications were Granted?

Cleerly (Excluding its subsidiaries) has filed 33 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 23 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Cleerly patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Cleerly?

Law FirmTotal ApplicationsSuccess Rate
Knobbe Martens Olson & Bear Llp28100.00%
Knobbe Martens Olson & Bear Llp Cleer50%

What are Cleerly key innovation segments?

What Technologies are Covered by Cleerly?

The chart below distributes patents filed by Cleerly in different countries on the basis of the technology protected in patents. It also represents the markets where Cleerly thinks it’s important to protect particular technology inventions.

R&D Focus: How has Cleerly search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cleerly?

Related Articles

Celcem Patents – Insights & Stats (Updated 2024)

Celcem has a total of 28 patents globally, out of which all patents have been granted. Of these 28 patents, all patents patents are active. Singapore is where Celcem has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.